Skip to main content
VCbacked
Log inGet Started

Emalex Biosciences

Chicago, United States

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

$270.0M raised
Nov 2022
Series D
BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics

Top Investors

Valor Equity PartnersBain Capital Life SciencesFidelityHorizon Technology FinanceParagon Biosciences

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Emalex Biosciences

How much funding has Emalex Biosciences raised?
Emalex Biosciences has raised $270.0M in total funding. The most recent round was Series D. The last funding was announced in November 2022.
Who are Emalex Biosciences's investors?
Emalex Biosciences's investors include Valor Equity Partners, Bain Capital Life Sciences, Fidelity, Horizon Technology Finance, Paragon Biosciences.
Where is Emalex Biosciences headquartered?
Emalex Biosciences is headquartered in Chicago, United States.
What does Emalex Biosciences do?
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
What stage is Emalex Biosciences at?
Emalex Biosciences is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Emalex Biosciences — Funding & Investors." VCBacked, November 3, 2022, https://www.vcbacked.co/company/emalex-biosciences. Accessed July 2, 2026.
APA
VCBacked. (2022). Emalex Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/emalex-biosciences
Wikipedia (cite web)
{{cite web |title=Emalex Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/emalex-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M